Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38556
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorBURZYKOWSKI, Tomasz
dc.contributor.advisorCRASS, Ryan
dc.contributor.advisorBYON, Wonkyung
dc.contributor.authorNhim, Malai
dc.date.accessioned2022-09-26T08:21:18Z-
dc.date.available2022-09-26T08:21:18Z-
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/1942/38556-
dc.format.mimetypeApplication/pdf
dc.languageen
dc.publishertUL
dc.titleEfficacy and Safety of Ibrutinib Alone or as Combination Treatment in Patients with non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
dc.typeTheses and Dissertations
local.bibliographicCitation.jcatT2
dc.description.notesMaster of Statistics and Data Science-Biostatistics
local.type.specifiedMaster thesis
item.contributorNhim, Malai-
item.fulltextWith Fulltext-
item.fullcitationNhim, Malai (2022) Efficacy and Safety of Ibrutinib Alone or as Combination Treatment in Patients with non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.-
item.accessRightsOpen Access-
Appears in Collections:Master theses
Files in This Item:
File Description SizeFormat 
db37e5ca-8672-4254-888d-1b7e424fc94a.pdf1.6 MBAdobe PDFView/Open
Show simple item record

Page view(s)

68
checked on Sep 10, 2023

Download(s)

108
checked on Sep 10, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.